Exhibit 10.2
BOARD RIGHTS AGREEMENT
This BOARD RIGHTS AGREEMENT (this “Agreement”) is made as of [AGREEMENT DATE] by and between Air Water Ventures Corporation (formerly known as Air Water Ventures Limited), a corporation domesticated in the State of Delaware following its de-registration and transfer by way of continuation out of the Cayman Islands (“Parent”), and Breakthrough Energy Ventures Select Fund I, L.P., a Delaware limited partnership (the “Designating Entity”). Parent and the Designating Entity are each a “Party” and together the “Parties.”
RECITALS
** **
WHEREAS Parent, Second Spring Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”), Second Spring Water, Inc., a Delaware corporation (the “Company”), AWVH Limited, a Cayman Islands exempted company, and the Designating Entity, are parties to that certain Agreement and Plan of Merger dated as of November 16, 2026 (as amended in accordance with its terms, the “Merger Agreement”); and
** **
WHEREAS Section 5.14 of the Merger Agreement contemplates that, effective at the Closing, the Designating Entity will have the right to designate one member of the Board on the terms of this Agreement.
** **
NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the Parties agree as follows.
1. DEFINITIONS
1.1 Incorporated Terms. Capitalized terms used but not defined in this Agreement have the meanings given to them in the Merger Agreement, and the Merger Agreement controls to the extent of a conflict concerning a right or obligation under it.
1.2 Defined Terms. The following terms have the meanings set forth below:
(a) “Applicable Requirements” means, as applicable to Parent or a director of Parent, the DGCL and the Parent Charter Documents, the fiduciary duties applicable to a director of Parent under Delaware law and other applicable Law, the rules of The Nasdaq Stock Market LLC, the United States federal securities laws, and Parent’s written governance, conflict-of-interest, information-security, securities-trading, compensation-recovery and document-retention policies applicable to directors of Parent generally.
(b) “Board” means Parent’s board of directors.
(c) “Cause” means, with respect to a Designated Director, that the Board determines in good faith, after written notice to the Designated Director and the Designating Entity describing the grounds in reasonable detail and a reasonable opportunity for the Designated Director to respond to the Board, that the Designated Director is disqualified from service under Applicable Requirements, has been convicted of or has pleaded guilty or nolo contendere to a felony or a crime involving fraud, dishonesty or breach of trust, has been found by a court or Governmental Authority, in a final determination that is no longer subject to appeal, to have engaged in fraud, willful misconduct or a breach of fiduciary duty, or has materially breached the Nominee Undertaking. A good-faith exercise of fiduciary judgment, including a vote or position taken in opposition to the Board majority or to Parent management, is not Cause.
(d) “Designated Director” means an individual designated by the Designating Entity under this Agreement and then serving on the Board.
(e) “Designation Period” means the period beginning at the Closing and ending on the earlier of (i) the last day of the Earnout Period and (ii) the date on which the Designating Entity and its Affiliates collectively beneficially own fewer than fifty percent of the Initial Ownership Amount.
(f) “Designation Right” means the Designating Entity’s right during the Designation Period to designate one individual for one seat on the Board.
(g) “Initial Ownership Amount” means the sum of (i) the shares of Domesticated Parent Common Stock acquired, directly or indirectly, by the Designating Entity or its Affiliates in connection with the Closing and (ii) the shares of Domesticated Parent Common Stock issuable upon conversion or exercise of Parent securities so acquired by them, in each case equitably adjusted for a share split, combination, recapitalization or similar event. Beneficial ownership is determined under Rule 13d-3 under the Exchange Act, except that Parent securities acquired in connection with the Closing are treated as converted or exercised without regard to the sixty-day limitation in that rule, and no share of Domesticated Parent Common Stock is counted more than once. Initial Ownership Amount shall not include the Closing Escrow Shares. For the fifty percent test in the definition of Designation Period, only the Parent securities included in the Initial Ownership Amount, and securities received upon conversion, exercise, exchange or substitution of, or an equitable corporate-action adjustment in respect of, those securities, are counted, and Parent securities acquired after the Closing from another source do not offset a disposition of securities included in the Initial Ownership Amount.
(h) “Nominee Undertaking” means the confidentiality, compliance and advance-resignation undertaking in the form attached as Annex A, executed by a nominee and delivered to Parent.
(i) “Parent Charter Documents” means Parent’s certificate of incorporation and bylaws, as in effect from time to time.
(j) “Parent Subsidiary” means an entity directly or indirectly controlled by Parent.
2. DESIGNATION RIGHT
2.1 One Designated Seat. During the Designation Period, the Designating Entity may designate one individual to serve on the Board. The Designation Right applies to exactly one Board seat and may not be exercised to designate, remove or replace more than one director at a time.
2.2 Nominee Qualifications. Each individual designated under this Agreement must satisfy the Applicable Requirements, including any independence requirement applicable to the designated seat, must not be subject to a statutory or regulatory disqualification or otherwise be disqualified from service as a director of a Nasdaq-listed company, and must deliver the items described in Section 2.3. Initial appointment, continued nomination, replacement and committee eligibility are in each case subject to the individual’s continuing satisfaction of those requirements throughout that individual’s Board service.
2.3 Designation Notice; Information. The Designating Entity exercises the Designation Right by delivering a written notice to Parent identifying the nominee and enclosing the nominee’s completed director and officer questionnaire in Parent’s customary form, the nominee’s consent to a customary background check, the background and conflicts information Parent reasonably requests, the nominee’s written consent to serve and to be named in Parent’s filings, and the nominee’s executed Nominee Undertaking.
2.4 Qualification Review; No Deemed Appointment. The Board (or an authorized committee of the Board) shall review a proposed nominee promptly and in good faith and may reject a nominee only for failure to satisfy the requirements of Section 2.2 or Section 2.3, stating the grounds in reasonable detail and permitting the Designating Entity to designate a replacement. A nominee is not appointed or elected solely by delivery of a designation notice, and appointment or election requires the corporate action described in Section 3.1.
23. APPOINTMENT, NOMINATION AND ELECTION
3.1 Initial Appointment. Subject to the nominee’s satisfaction of the requirements of Section 2.2 and Section 2.3 and to the Board’s applicable fiduciary duties, Parent shall take all corporate action necessary so that the individual initially designated by the Designating Entity is appointed to the Board effective at the Closing. The initial nominee is Paul Deninger. The appointment resolutions shall acknowledge the advance resignation contained in the Nominee Undertaking.
3.2 Continued Nomination; Anti-Impairment. During the Designation Period, whenever the Designated Director’s term expires or the Designated Director is otherwise required to stand for election, Parent shall nominate the Designated Director, recommend that stockholders vote in favor and solicit proxies for that election to the same extent as for Parent’s other director nominees, in each case subject to the Designated Director’s continuing satisfaction of the Applicable Requirements and to the Board’s applicable fiduciary duties. During the Designation Period, Parent shall not reduce the size of the Board in a manner that would eliminate the Designated Director’s seat, amend its governing documents in a manner that would impair the Designation Right or take any other action that has the effect of impairing the Designation Right without the prior written consent of the Designating Entity.
3.3 Separate Independent Seat. This Agreement governs one Designating Entity seat only. The appointment of John Reale, or the initial selection of a mutually agreed independent director for that seat, is governed by the Merger Agreement, and this Agreement creates no designation, nomination, replacement or approval right with respect to that seat.
4. VACANCY, REPLACEMENT, REMOVAL AND END OF PERIOD
4.1 Replacement and Vacancy. During the Designation Period, the Designating Entity may replace the Designated Director by written notice to Parent, effective upon the resignation of the incumbent Designated Director, subject to the requirements of Section 2.2 and Section 2.3. If the Designated Director dies, becomes incapacitated, resigns, is removed or otherwise ceases to serve, the Designating Entity may designate a replacement, and, subject to the requirements of Section 2.2 and Section 2.3 and to the Board’s applicable fiduciary duties, Parent shall take the corporate action necessary to promptly fill the vacancy with the qualified replacement.
4.2 Removal. Parent shall not cause or support removal of the Designated Director during the Designation Period except at the written direction of the Designating Entity or for Cause. If stockholder action is required to remove the Designated Director for Cause, Parent may recommend and solicit that action after the Board makes the determination described in the definition of Cause. Notwithstanding the foregoing, Parent may cause or support removal of the Designated Director if the Board determines in good faith, on the advice of counsel, that removal is required by applicable Law, the Parent Charter Documents, a binding regulatory requirement or the fiduciary duties of the directors; provided that, before taking any action to cause or support removal based on the fiduciary duties of the directors, Parent shall, to the extent legally permissible and practicable, provide the Designating Entity with at least five (5) Business Days’ prior written notice of the proposed action and a reasonable opportunity to consult with Parent before such action is taken; provided, further, that Parent shall not be required to delay such action if the Board determines in good faith, on the advice of counsel, that such delay would be inconsistent with applicable Law or the fiduciary duties of the directors. Parent shall promptly give the Designating Entity written notice of that determination, and if the Designation Period continues the Designating Entity may designate a replacement under Section 4.1.
4.3 End of Designation Period. Delivery to Parent of an executed Nominee Undertaking, which contains the advance resignation, is a condition to appointment. The advance resignation takes effect in accordance with its terms, unless the Board determines, in accordance with paragraph 8 of the Nominee Undertaking, that the advance resignation shall not take effect, and when the Designation Period ends Parent has no further obligation under this Agreement to nominate, recommend, appoint or replace the Designated Director. If the Designated Director has not ceased to serve on the Board when the Designation Period ends, then, unless the Board has made that determination or otherwise requests in writing, the Designating Entity shall use commercially reasonable efforts to cause the Designated Director to resign from the Board promptly, and in any event within five Business Days, after the end of the Designation Period.
35. BOARD SERVICE; INFORMATION; PROTECTIONS
5.1 Board Participation and Materials. While serving on the Board, the Designated Director is entitled to the same notice, meeting materials, access to management and other rights and privileges afforded to Parent’s other nonexecutive directors generally, subject to Section 5.2 and to Applicable Requirements. The Designated Director shall be eligible to serve as a member of any committee of the Board, subject to Section 5.2 and the applicable independence and qualification requirements, provided that any committee appointment shall remain subject to the Board’s discretion.
5.2 Privilege, Conflicts and Legal Limits. The Board, or Parent acting on the Board’s authority, may withhold or redact information from the Designated Director, or limit the Designated Director’s participation in a matter, to the same extent it may do so with respect to another similarly situated director, and only if the Board or Parent determines in good faith, on the advice of counsel, that the action is reasonably necessary to preserve attorney-client privilege or work-product protection, to comply with applicable Law or a confidentiality obligation owed to another Person, to address an actual conflict of interest involving the Designated Director or the Designating Entity, or to address a dispute or proposed transaction between Parent or a Parent Subsidiary and the Designated Director, the Designating Entity or one of its Affiliates. Any withholding, redaction or limitation must be no broader than reasonably necessary, and Parent shall use reasonable efforts to provide nonprivileged or redacted information where doing so would address the concern.
5.3 Fiduciary Duties; No Information Right. The Designated Director shall discharge the duties of a director of Parent in accordance with applicable Law and the Parent Charter Documents, and nothing in this Agreement obligates the Designated Director to act at the direction of the Designating Entity. Each contractual obligation of a Designated Director arises solely under the Nominee Undertaking executed by that individual. This Agreement grants the Designating Entity no right to receive nonpublic information concerning Parent or a Parent Subsidiary, except as provided in the following sentence. Notwithstanding the foregoing, nothing in this Section 5.3 shall prevent the Designated Director from sharing with the Designating Entity information that (a) is reasonably necessary for the Designating Entity to evaluate its investment in Parent and (b) is shared in accordance with an information-sharing protocol agreed to in writing by Parent and the Designating Entity, subject to Parent’s reasonable confidentiality requirements and Section 5.13 of the Merger Agreement. Without Parent’s prior written consent, the Designating Entity shall not request that the Designated Director disclose, or knowingly accept from the Designated Director, information in violation of the Nominee Undertaking.
5.4 Indemnification, Insurance, Expenses and Compensation. While serving as a director, and thereafter with respect to service occurring during that period, the Designated Director is entitled to indemnification, advancement and exculpation, is included in Parent’s directors’ and officers’ liability insurance, and is reimbursed for reasonable documented out-of-pocket expenses of Board service in accordance with Parent’s policies, in each case, on the same basis as Parent’s other nonexecutive directors. The Designated Director shall be entitled to receive compensation for service as a director, including cash fees, equity awards and other benefits, on the same basis as Parent’s other nonexecutive directors generally.
5.5 Public-Company Compliance. The Designating Entity shall provide the information concerning the Designating Entity and its Affiliates that Parent reasonably requires for its filings, listing compliance and governance determinations, and shall promptly notify Parent of a change known to it that would reasonably be expected to affect the Designated Director’s independence, eligibility or disclosure status. The Designating Entity shall notify Parent promptly after it becomes aware that the Designating Entity and its Affiliates collectively beneficially own fewer than fifty percent of the Initial Ownership Amount, and shall provide, upon Parent’s reasonable request, information reasonably sufficient to determine whether the Designation Period continues. That obligation extends only to the securities counted under the definition of Initial Ownership Amount and their permitted replacements and substitutions.
46. TERMINATION; SURVIVAL
6.1 Effectiveness; Termination; Survival. This Agreement becomes effective at the Closing. The Designation Right and Parent’s related nomination, appointment and replacement obligations end when the Designation Period ends. Rights and obligations that accrued before that time, and the provisions of this Agreement whose nature requires that they apply to Board service occurring during the Designation Period, survive.
7. ASSIGNMENT; REMEDIES
7.1 Assignment. Parent may assign this Agreement without consent only to a successor to Parent in a merger, consolidation, scheme of arrangement, reorganization or similar transaction if that successor assumes Parent’s obligations under this Agreement by operation of law or in writing and the Designation Right applies to the successor’s board of directors for the unexpired Designation Period. Any other assignment by Parent requires the Designating Entity’s written consent, and a purported assignment that does not preserve an enforceable equivalent right does not release Parent from its obligations under this Agreement. The Designating Entity may not assign or transfer the Designation Right without Parent’s prior written consent. An assigning Designating Entity remains liable for obligations that accrued before the assignment. A purported assignment in violation of this Section is void.
7.2 Remedies. The Parties acknowledge that a breach or threatened breach of this Agreement would cause irreparable harm for which monetary damages would not be an adequate remedy, and each Party may seek specific performance, injunction and other equitable relief without posting a bond. A claim under this Agreement may be asserted only against a Party and is not subject to the Recovery Waterfall, the Holder Cap or another limitation applicable to a claim under Article VI or Article VIII of the Merger Agreement.
7.3 Representations. Each Party represents and warrants to the other that it has the power and authority to execute, deliver and perform this Agreement and that this Agreement is, subject to the Enforceability Exceptions, its valid and binding obligation.
8. GENERAL PROVISIONS
8.1 Notices. Each notice under this Agreement shall be in writing and is deemed given when delivered by hand with written confirmation, on receipt if sent by nationally recognized overnight courier, or on transmission if sent by email without a delivery-failure notice, in each case to the addresses stated on Annex B, as updated by written notice.
8.2 Amendment; Waiver. This Agreement may be amended, modified or supplemented only by a writing signed by both Parties. A waiver is effective only if in writing and signed by the Person entitled to its benefit, applies only to the identified instance and does not waive a later or different breach.
8.3 Governing Law; Forum; Jury Waiver. This Agreement and each claim arising from or relating to it are governed by Delaware law, without regard to a choice-of-law rule requiring another jurisdiction’s law. Each Party irrevocably submits to the exclusive jurisdiction of the Delaware Courts and waives objections based on venue or inconvenient forum. EACH PARTY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY ACTION ARISING FROM OR RELATING TO THIS AGREEMENT.
8.4 Interpretation; Severability; Counterparts. Unless the context otherwise requires, “including” means “including without limitation,” “or” is not exclusive, the singular includes the plural and vice versa, and headings are for convenience only. If a provision is held invalid, illegal or unenforceable, the remaining provisions remain effective, and the invalid, illegal or unenforceable provision will be deemed modified to the minimum extent necessary to make it valid, legal and enforceable while preserving the Parties’ original intent. This Agreement may be executed in counterparts, each deemed an original and all of which constitute one instrument, and a PDF or legally effective electronic signature has the same effect as an original.
8.5 Entire Agreement; Beneficiaries. This Agreement constitutes the entire agreement between Parent and the Designating Entity concerning the Designation Right and supersedes prior discussions and agreements concerning that subject matter, and Section 1.1 governs the relationship between this Agreement and the Merger Agreement. Each Designated Director is an intended third-party beneficiary solely of Section 5.4, and no other Person is an intended third-party beneficiary.
[SIGNATURE PAGE FOLLOWS]
5IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.
AIR WATER VENTURES CORPORATION
| By: | ||
| Name: | Peter Carr | |
| Title: | Authorized Signatory |
BREAKTHROUGH ENERGY VENTURES SELECT FUND I, L.P.
| By: | ||
| Name: | Carmichael Roberts | |
| Title: | Managing Partner |
[Signature Page to Board Rights Agreement]
6ANNEX A
FORM OF NOMINEE CONFIDENTIALITY, COMPLIANCE AND ADVANCE-RESIGNATION UNDERTAKING
This NOMINEE UNDERTAKING (this “Undertaking”) is made as of [DATE] by [NOMINEE LEGAL NAME] (the “Director”) for the benefit of Air Water Ventures Corporation, a Delaware corporation (“Parent”). Capitalized terms used but not defined in this Undertaking have the meanings given to them in the Board Rights Agreement dated as of [AGREEMENT DATE] between Parent and Breakthrough Energy Ventures Select Fund I, L.P. (the “Board Rights Agreement”). Parent joins this Undertaking solely for the obligations expressly imposed on Parent in paragraphs 3 and 8, and Parent is not an obligor under any other provision of this Undertaking.
** **
WHEREAS the Director has been designated for service on the Board under the Board Rights Agreement, and as a condition to appointment the Director agrees to protect Parent’s Confidential Information, to comply with the requirements applicable to Parent’s directors and to deliver the advance resignation set forth below.
** **
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are acknowledged, the Director agrees as follows.
| 1. | “Confidential Information” means all nonpublic information in any form concerning Parent or a Parent Subsidiary that is furnished or made available to the Director in connection with Board service, together with all analyses and notes derived from it. Confidential Information does not include information that becomes generally available to the public other than through a breach of this Undertaking, was lawfully available to the Director on a nonconfidential basis before disclosure by or on behalf of Parent or a Parent Subsidiary, was lawfully received by the Director after that disclosure from a source not known by the Director, after reasonable inquiry, to be subject to a duty of confidentiality to Parent or a Parent Subsidiary, or was independently developed by the Director without use of Confidential Information. |
| 2. | The Director shall preserve the confidentiality of Confidential Information and use it solely to perform the Director’s duties to Parent. The Director may use and disclose Confidential Information within Parent and the Parent Subsidiaries to directors, officers, employees and advisers who need it for the Director’s good-faith performance of Board duties and whose receipt is consistent with applicable duties and Parent’s policies. The Director shall not disclose Confidential Information to the Designating Entity or its Affiliates or representatives, or to another third party, except with Parent’s prior written consent, as expressly permitted by Section 5.3 of the Board Rights Agreement or as paragraphs 3 and 4 permit. |
| 3. | If the Director is required by applicable Law, legal process or a Governmental Authority to disclose Confidential Information, the Director may disclose only the portion legally required and shall, to the extent legally permitted and practicable, give Parent notice before disclosure and reasonably cooperate, at Parent’s expense, in seeking a protective order or other confidential treatment. |
| 4. | Nothing in this Undertaking prohibits or restricts the Director from reporting a possible violation of Law to a Governmental Authority, from communicating with or participating in an investigation or proceeding conducted by a Governmental Authority, including the Securities and Exchange Commission, from making another disclosure that is protected under applicable Law or from receiving a whistleblower award from a Governmental Authority. No prior notice to, or consent from, Parent is required for that report, communication, participation or disclosure. |
| 5. | The Director shall comply with Parent’s written governance, conflict-of-interest, information-security, securities-trading, compensation-recovery and document-retention policies applicable to nonemployee directors generally, as those policies are in effect from time to time. |
| 6. | The Director shall deliver to Parent a completed director and officer questionnaire in Parent’s customary form, the Director’s consent to a customary background check, the Director’s written consent to serve and to be named in Parent’s filings, and the background, conflicts and disclosure information Parent reasonably requests, and shall promptly update that information while the Director serves on the Board. |
| 7. | The Director shall promptly notify Parent of any fact or change that would reasonably be expected to affect the Director’s eligibility, independence or disclosure status or the Director’s continued satisfaction of the Applicable Requirements. |
| 8. | The Director irrevocably tenders the Director’s resignation from the Board to take effect at the end of the Designation Period, unless, before the end of the Designation Period, the Board, by resolution adopted by a majority of the directors then in office (excluding the Director), determines that the resignation shall not take effect. Subject to the preceding sentence, that resignation is effective at the end of the Designation Period without further action to the fullest extent permitted by the DGCL and the Parent Charter Documents. To the extent effectiveness requires acceptance by the Board or another corporate action, the resignation takes effect when that action is taken, Parent shall take the corporate action that Parent’s counsel confirms is necessary to give the resignation effect, and the Director shall not withdraw or revoke the resignation. Notwithstanding the foregoing, the advance resignation shall be of no force or effect if the Director is reappointed or re-elected to the Board outside of this Agreement following the expiration of the Designation Period. Nothing in this paragraph requires the Director to act contrary to applicable Law or to a fiduciary duty owed to Parent. |
| 9. | Paragraphs 1 through 4 apply immediately to information disclosed to the Director before the Closing in contemplation of Board service. Paragraphs 5 through 8 become effective upon the Director’s appointment to the Board. If the Merger Agreement is terminated before the Closing and the Director is never appointed, this Undertaking terminates, except that paragraphs 1 through 4 continue with respect to Confidential Information already received. |
| 10. | The Director’s obligations under paragraphs 1 through 4 continue for so long as the information remains Confidential Information, and with respect to Confidential Information that constitutes a trade secret under applicable Law, for so long as it remains protected as a trade secret. |
| 11. | The Director acknowledges that a breach or threatened breach of this Undertaking would cause irreparable harm for which monetary damages would not be an adequate remedy, and Parent may seek specific performance, injunction and other equitable relief without posting a bond. This Undertaking is personal to the Director, may not be assigned or delegated, and may be amended or waived only by a writing signed by the Director and Parent. |
| 12. | Sections 8.3 and 8.4 of the Board Rights Agreement are incorporated into this Undertaking, mutatis mutandis, and apply to this Undertaking as though set forth in it, with the Director treated as a party solely for those incorporated provisions. |
| [NOMINEE LEGAL NAME] | |
| [NOMINEE LEGAL NAME] |
| Agreed and Accepted Solely as Provided Above: | ||
| AIR WATER VENTURES CORPORATION | ||
| By: | ||
| Name: | ||
| Title: |
ANNEX B
NOTICE INFORMATION
| Party | Notice address, attention and email | Counsel copy |
| Air Water Ventures Limited | 4341 W. 108th St., Suite 1, Hialeah, FL 33018 Attention: David Tuerff, Chief Financial Officer Email: david.tuerff@a1rwater.com **** | Reed Smith LLP, 2850 N. Harwood Street, Suite 1500 Dallas, TX 75201 Attention: Lyn Reinhardt and Jocelyne Kelly Email: lreinhardt@reedsmith.com; jocelyne.kelly@reedsmith.com **** |
| Breakthrough Energy Ventures Select Fund I, L.P. | [DESIGNATING ENTITY NOTICE ADDRESS; ATTENTION; EMAIL] | [COUNSEL NAME; ADDRESS; ATTENTION; EMAIL] |